• / Free eNewsletters & Magazine
  • / My Account
Home>Finance>Food>Food And Drug Administration

Food And Drug Administration

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Retrophin Sells FDA Voucher to Sanofi for $245 Million -- Update

    Retrophin Sells FDA Voucher to Sanofi for $245 Million -- Update

  2. Roche receives FDA clearance for the cobas® Cdiff Test to detect Clostridium difficile

    Roche receives FDA clearance for the cobas® Cdiff Test to detect Clostridium difficile

  3. Cerulean’s CRLX101 Receives Orphan Drug Designation from the FDA for the Treatment of Ovarian Cancer

    Cerulean’s CRLX101 Receives Orphan Drug Designation from the FDA for the Treatment of Ovarian Cancer

  4. CareFusion Provides Update on Voluntary Global Recall of AVEA® Ventilator

    CareFusion Provides Update on Voluntary Global Recall of AVEA® Ventilator

  5. Taro Provides Results for Year Ended March 31, 2015

    Taro Provides Results for Year Ended March 31, 2015

  6. Coke Says It Is Ready To Let In Monster

    Coke Says It Is Ready To Let In Monster

  7. UPDATE: 10 uncomfortable truths about the midlife crisis

    UPDATE: 10 uncomfortable truths about the midlife crisis

  8. UPDATE: U.S. stocks fall; Dow down by triple digits

    UPDATE: U.S. stocks fall; Dow down by triple digits

  9. MARKET SNAPSHOT: U.S. Stocks Sell Off; Dow Down By Triple Digits

    MARKET SNAPSHOT: U.S. Stocks Sell Off; Dow Down By Triple Digits

  10. Eagle Pharmaceuticals Submits NDA for Ready-to-Use Bivalirudin to FDA

    Eagle Pharmaceuticals Submits NDA for Ready-to-Use Bivalirudin to FDA

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.